NCT04699123 2025-05-13The Study of NC318 Alone or in Combination With Pembrolizumab in Patients With Advanced Non-small Cell Lung CancerYale UniversityPhase 2 Active not recruiting159 enrolled
NCT06868732 2025-03-11Evaluation of JSKN016 Combination Therapy in Subjects with NSCLCJiangsu Alphamab Biopharmaceuticals Co., LtdPhase 1 Not yet recruiting288 enrolled